The problem would be for existing share holders in Australia that would see the value of their shares diminished with the introduction of additional shares - otherwise I agree
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025